Approval · Notice of Compliance 14493 · 2013
AJ-VANCOMYCIN: Notice of Compliance 14493
Issued June 26, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14493
- Date
- June 26, 2013
- Company
- Agila Jamp Canada IncEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative licensing agreement between two companies
- Therapeutic class
- Antibiotic
- Canadian reference product
- PMS-VANCOMYCIN (Pharmascience Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AJ-VANCOMYCIN | 02407914 | Cancelled Post Market |
| AJ-VANCOMYCIN | 02407922 | Cancelled Post Market |
| AJ-VANCOMYCIN | 02407930 | Cancelled Post Market |
| AJ-VANCOMYCIN | 02407949 | Cancelled Pre Market |
Medicinal ingredients
- VANCOMYCIN HYDROCHLORIDE 500 MG per VIAL
- VANCOMYCIN HYDROCHLORIDE 1 G per VIAL
- VANCOMYCIN HYDROCHLORIDE 5 G per VIAL
- VANCOMYCIN HYDROCHLORIDE 10 G per VIAL